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INTRODUCTION
Anorectal melanoma is an uncommon and aggressive
cancer with an unfavorable prognosis
2-5,7,9-11 and a pre-
dilection for early infiltration and distant spread, resulting
in poor overall survival.
2 It represents approximately 1
percent of all anorectal malignancies.
7,11 Between 0.4% and
1.6% of all melanomas arise in the anorectal region, and the
anal canal is the most frequent site of melanoma after the
skin and retina.
11 Most patients are female.
2,3 The first case
of the disease was reported by Moore in 1857 and, so far,
approximately 500 cases have been reported in the
literature.
11
Because anal melanoma is rare, only small case series
have been reported in the literature, making it difficult for
one to draw conclusions about optimal treatment and
outcome.
2 The surgical management of patients with
anorectal melanoma is controversial.
1 Some authors have
stated that wide local resection is the first choice for primary
anorectal melanoma if negative margins can be achieved
when this is technically feasible and complete tumor
resection is impossible.
3,5 Abdominoperineal resection
should be reserved for large tumors where wide local
excision is not technically possible.
5 Chemotherapy, radio-
therapy, and immunotherapy should be considered in the




We report the case of a 76-year-old man who presented
with a four-month history of rectal bleeding, pain, tenes-
mus, and 3kg weight loss. A semicircular rectal tumor was
seen just above the dentate line. Biopsies demonstrated that
it was an amelanotic malignant melanoma since protein
S100, melanoma antigen HMB45, and Melan-A expression
were found. MRI revealed circumferential thickening due to
rectal lesion with a 7.2 cm length and 1.8 cm thickness,
leading to narrowing of the rectal lumen located 3.2 cm
away from the anus and several enlarged perirectal nodes
(Figure 1). No distant lesions were detected upon computed
tomography scan. An abdominoperineal resection was
performed because a substantial part of the internal anal
sphincter was invaded (Figure 2). Histology (Figures 3, 4, 5)
confirmed a malignant metastatic, epithelioid melanoma in
13 of the 14 examined lymph nodes.
The patient recovered well from the operation, was
released on the 6th postoperative day, and was referred to
an oncologist. Thirty days postoperatively, the individual
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Figure 1 - Magnetic resonance imaging showing rectal neoplasm
(A) and perirectal nodes (B).
Figure 2 - The rectum, the large nodes, and the tumor after an
abdominalperineal resection.
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1063presented with abdominal pelvic ganglionar and pulmon-
ary and hepatic metastases, progressed to bilateral urethral
obstruction due to neoplasic invasion, and died of renal
failure.
DISCUSSION
Anorectal melanoma is an uncommon and aggressive
cancer with an unfavorable prognosis.
2-5,7,9,10 It is more
common in females,
2,3,6 and the mean age of disease onset is
60 years.
6 It is characterized by unspecific symptoms, and
differential diagnosis with other lesions of the rectum and
anus is often difficult.
7 The most common complaints are
bleeding, rectal pain, tenesmus, and changes in bowel
habits. At the histological examination, the presence of
protein S-100, melanoma antigen HMB-45, and Melan-A
expression are strongly suggestive of melanoma.
4
The overall survival time is 10-19 months after diagno-
sis.
1,3 The prognosis of primary malignant anorectal
melanoma is poor, irrespective of surgical treatment.
3
Survival is improving, but the use and extent of operation
are not associated with improved overall survival rates.
2
Neither age at diagnosis, performed operation, nor use of
radiation significantly affect survival.
2
The surgical management of patients with anorectal
melanoma is controversial.
1,5-10 Despite surgical resection
and the emergence of various forms of adjuvant therapy, the
overall prognosis of anorectal melanoma remains the same.
Radical surgery is, when possible, the most effective
therapeutic option for the treatment of primary and
metastatic melanomas since chemotherapy and radiother-
apy do not lead to the same results in terms of cure in these
patients.
11 Abdominoperineal excision of the rectum (APER)
is the first choice for patients with anorectal melanoma,
particularly those with smaller tumors and no evidence of
nodal metastases.
1,6
Other authors have claimed that wide local excision
(WLE) is the preferred treatment where negative margins
can be achieved and that APER should be reserved for cases
in which complete tumor resection is impossible, for
instance when the tumor invades a substantial portion of
the anal sphincter or is circumferential.
3-5,7-10
A recent article has shown that the survival rate of
patients with anal melanoma is similar after local excision or
rectal resection, irrespective of whether patients have the
localized or regional stage of the disease.
12
Adjuvant radiation therapy is well-tolerated and promis-
ing in improving loco-regional control.
10 The final outcome
is not influenced by surgery modality. A limited but radical
excision can be considered whenever possible, while a
major demolitive surgery should be applied for therapy of
advanced or bulky lesions only.
11
Despite the radical surgery performed in the present case,
local relapse and distant metastases occurred within only a
month. It was not possible to carry out chemotherapy or
adjuvant radiotherapy because of the subject’s poor clinical
conditions and renal failure due to bilateral urethral
obstruction, one of the direct causes of his death.
In this case, abdominoperineal amputation was necessary
due to tumor size and extension. Chemotherapy, radio-
therapy, and immunotherapy should be considered in the
treatment of anorectal melanoma in order to influence
overall survival. However, the results are limited.
3
Figure 3 - Anal melanoma. Cross-section of the external surface
region (H&E 6100).
Figure 4 - Anal melanoma. Cross-section of the mucosa surface
region (H&E 6100).
Figure 5 - Anal melanoma. Cross-section of the tumor region
(H&E 6400).
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